ARS Pharmaceuticals Inc. (SPRY)
14.69
0.24 (1.66%)
At close: Jan 28, 2025, 1:46 PM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | 30.00K | 1.32M | 5.51M | 17.84M | n/a | n/a |
| Cost of Revenue | 73.00K | 17.32M | 20.27M | 14.07M | 1.55M | 1.42M |
| Gross Profit | -43.00K | -16.00M | -14.77M | 3.77M | -1.55M | -1.42M |
| Operating Income | -67.52M | -35.52M | -19.45M | -469.00K | -24.07M | -18.32M |
| Interest Income | n/a | n/a | 800.00K | 400.00K | 100.00K | 43.00K |
| Pretax Income | -54.37M | -34.68M | -20.24M | -1.06M | -23.97M | -17.58M |
| Net Income | -54.37M | -33.99M | -20.24M | -1.06M | -23.97M | -17.58M |
| Selling & General & Admin | 47.28M | 18.46M | 4.69M | 4.23M | 1.02M | 2.10M |
| Research & Development | 20.27M | 18.38M | 20.27M | 14.07M | 21.50M | 14.80M |
| Other Expenses | n/a | 974.00K | -789.00K | -596.00K | n/a | n/a |
| Operating Expenses | 67.55M | 36.83M | 24.96M | 18.30M | 22.52M | 16.90M |
| Interest Expense | n/a | n/a | 106.00K | 29.00K | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 67.55M | 36.83M | 24.96M | 18.30M | 24.07M | 18.32M |
| Income Tax | n/a | -694.00K | -230.56K | -200.30K | n/a | n/a |
| Shares Outstanding (Basic) | 95.22M | 39.96M | 28.87M | 34.70M | 33.07M | 33.07M |
| Shares Outstanding (Diluted) | 95.22M | 39.96M | 28.87M | 34.70M | 33.07M | 33.07M |
| EPS (Basic) | -0.57 | -0.85 | -0.7 | -0.03 | -0.72 | -0.53 |
| EPS (Diluted) | -0.57 | -0.85 | -0.7 | -0.03 | -0.72 | -0.53 |
| EBITDA | -67.45M | -35.52M | -19.24M | -463.00K | -22.52M | -16.90M |
| Depreciation & Amortization | 73.00K | 319.00K | 213.00K | 1.71M | 1.55M | 1.42M |